Top Markets
#1 Islamic Coin Islamic Coin +151.51%
#2 Akedo Akedo +69.87%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.42%
#5 Velvet Velvet +46.01%
#6 Cross Cross +36.90%
#7 Black Phoenix Black Phoenix +34.13%
#8 Cap Cap +19.51%
#9 DoubleZero DoubleZero +15.07%
#10 Humanity Humanity +11.75%
Coin of the day
Islamic Coin Islamic Coin
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Exopharm Limited Exopharm Limited

Exopharm Limited

EX1
Classificação em ações #39131
Exopharm Limited is an Australian clinical-stage firm dedicated to developing... Exopharm Limited is an Australian clinical-stage firm dedicated to developing groundbreaking therapeutics utilizing extracellular vesicles (EVs). Its core technologies include an extracellular vesicle positioning system (EVPS), which facilitates the precise targeting of exosomes by attaching specific molecules to their surface, guiding them to particular tissues or cell types. Another innovation is oligonucleotide packing, designed to optimize therapeutic delivery by preferentially loading specific RNA molecules into exosomes as medicinal cargo. Additionally, Exopharm employs ligand-based exosome affinity purification for effectively isolating and refining exosomes from biological fluids such as blood and cell culture media. The company's engineered EV product portfolio features Fortrexo CoV, aimed at treating SARS-CoV-2 infections; Cognevo, developed for neurodegenerative diseases; and PlexoDox, intended for cancer treatment. Exopharm Limited also maintains a research collaboration with Showa Denko Materials Co., Ltd. The company was founded in 2013 and is headquartered in Melbourne, Australia.
Preço da ação
$0.00700343
Última sincronização: 2023-10-30
Valor de mercado
$637.31K
Variação (1 dia)
0.50%
Variação (1 ano)
0.00%
País
AU
Negociar Exopharm Limited (EX1)

Categoria

Healthcare
Histórico de preços das ações de Exopharm Limited (EX1)
Preço de fecho mais alto: $0.01 em 2023-10-01

Preço de fecho mais baixo: $0.35 em 2018-12-01
Histórico de preços das ações da Exopharm Limited de 2018 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2023 -85.98%
2022 -83.97%
2021 9.37%
2020 40.18%
2019 -42.20%
2018 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 32.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 31.47%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.95 7.17%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.04 13.55%
BE